CLINICAL_TRIALS
trial_result
· 2021-12-23
Clinical Trial Update: Second-line Pazopanib Renal Cell Carcinoma (RCC) Study. CTRIAL-IE (ICORG) 10-01, V5 [Phase 2]
Summary
Phase 2 clinical trial update for second-line pazopanib in renal cell carcinoma.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Cancer Trials Ireland | Conditions: Renal Cell Carcinoma | Phase 2 | Status: COMPLETED